[FATE] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -23.29%
YoY- -39.79%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 18,414 11,142 2,515 2,632 1,026 1,027 1,322 55.08%
PBT -65,690 -45,089 -33,520 -19,760 -14,135 -10,126 -8,377 40.92%
Tax -8,777 -1,121 0 1,091 331 111 27 -
NP -56,913 -45,089 -33,520 -19,760 -14,135 -10,126 -8,377 37.60%
Tax Rate - - - - - - - -
Total Cost 75,327 56,231 36,035 22,392 15,161 11,153 9,699 40.70%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -309.07 -404.68 -1,332.80 -750.76 -1,377.68 -985.98 -633.66 -11.27%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.59 -0.48 -0.44 -0.30 -0.27 -0.24 -0.29 12.56%
EPS Diluted -0.59 -0.48 -0.44 -0.30 -0.27 -0.24 -0.29 12.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.